A Post Marketing Surveillance Study On Pregabalin (Lyrica) On Efficacy, Safety And Tolerability Of Pregabalin

Pregabalin (Lyrica) Action In Neuropathic Pain Syndrome (PAINS): A Post Marketing Surveillance Study On Efficacy, Safety And Tolerability Of Pregabalin

This study is being conducted as a regulatory requirement post initial marketing authorization. This is primarily a safety study. This was an open label study and patients were enrolled once the decision to prescribe the medication was made by the Investigator.

Inclusion Criteria:

• Male or female, 18 years old and above diagnosed with neuropathic pain.

Exclusion Criteria:

• Patients that are pregnant and lactating; and patients with known hypersensitivity to pregabalin or its related components.